| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $669.2M | +24.9% | -2.8% |
| Gross Profit | $530.1M | +28.6% | -1.0% |
| R&D Expense | $69.7M | +6.4% | +9.7% |
| SG&A Expense | $111.1M | +47.4% | +22.1% |
| Operating Income | $156.5M | +62.7% | -12.6% |
| Pre-tax Income | $84.2M | +124.9% | -12.5% |
| Income Tax | -$21.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $463.2M | +87.3% | — |
| Accounts Receivable | $666.8M | +49.9% | — |
| Inventory | $133.0M | -17.3% | — |
| Current Assets | $1.42B | +43.6% | — |
| Total Assets | $6.05B | +6.8% | — |
| Current Liabilities | $1.41B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $168.3M | +274.2% | — |
| Capital Expenditures | $37.5M | +130.2% | — |
| Investing Cash Flow | -$86.6M | -121.5% | — |
| Financing Cash Flow | -$8.4M | -13.1% | — |
| Free Cash Flow | $130.9M | +215.9% | — |
| -157.0% |
| +43.3% |
| Net Income | $105.3M | — | -21.1% |
| EPS (Basic) | $0.57 | — | -28.8% |
| EPS (Diluted) | $0.57 | — | -28.8% |
| +17.6% |
| — |
| Long-term Debt | $2.80B | -11.6% | — |
| Total Liabilities | $5.25B | -2.4% | — |
| Stockholders' Equity | $794.6M | +180.5% | +61.4% |